B. Riley Wealth Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-4,842
| Closed | -$209K | – | 598 |
|
|
2017
Q2 | $209K | Sell |
4,842
-1,186
| -20% | -$51.2K | 0.04% | 467 |
|
|
2017
Q1 | $253K | Sell |
6,028
-513
| -8% | -$21.5K | 0.05% | 399 |
|
|
2016
Q4 | $256K | Sell |
6,541
-15,361
| -70% | -$601K | 0.05% | 386 |
|
|
2016
Q3 | $968K | Buy |
21,902
+4,191
| +24% | +$185K | 0.19% | 140 |
|
|
2016
Q2 | $741K | Buy |
17,711
+1,831
| +12% | +$76.6K | 0.15% | 173 |
|
|
2016
Q1 | $639K | Hold |
15,880
| – | – | 0.15% | 170 |
|
|
2015
Q4 | $814K | Buy |
15,880
+1,150
| +8% | +$58.9K | 0.16% | 162 |
|
|
2015
Q3 | $692K | Buy |
14,730
+840
| +6% | +$39.5K | 0.17% | 166 |
|
|
2015
Q2 | $867K | Buy |
13,890
+1,600
| +13% | +$99.9K | 0.22% | 122 |
|
|
2015
Q1 | $759K | Buy |
12,290
+2,300
| +23% | +$142K | 0.19% | 147 |
|
|
2014
Q4 | $539 | Buy |
9,990
+550
| +6% | +$30 | 0.01% | 897 |
|
|
2014
Q3 | $500K | Sell |
9,440
-7,120
| -43% | -$377K | 0.13% | 208 |
|
|
2014
Q2 | $430K | Buy |
16,560
+8,880
| +116% | +$231K | 0.1% | 222 |
|
|
2014
Q1 | $359K | Buy |
7,680
+760
| +11% | +$35.5K | 0.11% | 222 |
|
|
2013
Q4 | $304K | Buy |
6,920
+600
| +9% | +$26.4K | 0.1% | 239 |
|
|
2013
Q3 | $243K | Sell |
6,320
-40
| -0.6% | -$1.54K | 0.08% | 274 |
|
|
2013
Q2 | $224K | Buy |
+6,360
| New | +$224K | 0.08% | 292 |
|